Your browser doesn't support javascript.
loading
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
Jackson, C G; Moore, K N; Cantrell, L; Erickson, B K; Duska, L R; Richardson, D L; Landrum, L M; Holman, L L; Walker, J L; Mannel, R S; Moxley, K M; Queimado, L; Cohoon, A; Ding, K; Dockery, L E.
Afiliação
  • Jackson CG; Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Moore KN; Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Cantrell L; Division of Gynecologic Oncology, University of Virginia, Department of Obstetrics and Gynecology; Charlottesville, VA, USA.
  • Erickson BK; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Minnesota; Minneapolis, MN, USA.
  • Duska LR; Division of Gynecologic Oncology, University of Virginia, Department of Obstetrics and Gynecology; Charlottesville, VA, USA.
  • Richardson DL; Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Landrum LM; Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Holman LL; Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Walker JL; Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Mannel RS; Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Moxley KM; Stephenson Cancer Center Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Queimado L; Department of Otolaryngology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Cohoon A; Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Ding K; Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center; Oklahoma City, OK, USA.
  • Dockery LE; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of North Carolina; Chapel Hill, NC, USA. Electronic address: lauren_dockery@med.unc.edu.
Gynecol Oncol ; 166(1): 44-49, 2022 07.
Article em En | MEDLINE | ID: mdl-35491267
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo do Útero / Neoplasias do Endométrio / Recidiva Local de Neoplasia Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo do Útero / Neoplasias do Endométrio / Recidiva Local de Neoplasia Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article